CAO Pharmaceuticals

CAO Pharmaceuticals

Early Stage

An Oral and Non-toxic Cancer Treatment Option

An Oral and Non-toxic Cancer Treatment Option


Raised to Date: Raised: $1,000

Total Commitments ($USD)


Silicon Prairie Online

Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common



SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Not Funded
Reporting Date


Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise


Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



Webster, Texas

Business Type


CAO Pharmaceuticals is testing the waters on Silicon Prairie Online. The pharmaceutical company specializes in oral and non-toxic cancer treatment options using camptothecin (cpt). The company is testing a cpt derivative, CZ48, for toxicity and efficiency against cancers of the bladder, breast, kidney, lungs, ovary, pancreas, and prostate. Zhisong Cao founded CAO Pharmaceuticals in May 2015. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5,000,000. The campaign proceeds will be used for the Phase 2 FDA trial, trial expenses, laboratory rental, utilities, expenses, and pipeline medication development.

Summary Profit and Loss Statement

Most Recent Year Prior Year












Net Income



Summary Balance Sheet

Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 05/01/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
CAO Pharmaceuticals on Silicon Prairie Online 2022
Platform: Silicon Prairie Online
Security Type: Equity - Common
Valuation: $1,000,000
Price per Share: $1.00

Follow company

Follow CAO Pharmaceuticals on Silicon Prairie Online 2022

Buy CAO Pharmaceuticals's Deal Report

Warning: according to the close date for this deal, CAO Pharmaceuticals may no longer be accepting investments.

CAO Pharmaceuticals Deal Report

Get KingsCrowd’s comprehensive report on CAO Pharmaceuticals including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CAO Pharmaceuticals is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CAO Pharmaceuticals deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge